US Stock MarketDetailed Quotes

CHRS Coherus BioSciences

Watchlist
  • 0.723
  • -0.022-2.95%
Close Nov 1 16:00 ET
  • 0.737
  • +0.014+1.91%
Post 19:58 ET
83.30MMarket Cap-1902P/E (TTM)

Coherus BioSciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Coherus BioSciences Q3 2024 Estimates Date

Currency：USDNov 6, 2024

Estimate YoY
Revenue
56.81M
-23.82%
EPS
-0.26
+36.72%
Analyst Rating
Strong Buy

Oct 31, 2024

Coherus BioSciences Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 56.300M--
Nov 6, 20242024/Q3-- / 56.806M--
Aug 8, 20242024/Q264.979M / 56.423M--
May 9, 20242024/Q177.063M / 83.747M--
Mar 13, 20242023/Q491.524M / 90.429M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 56.300M--
Nov 6, 20242024/Q3-- / 56.806M--
Aug 8, 20242024/Q264.979M / 56.423M--
May 9, 20242024/Q177.063M / 83.747M--
Mar 13, 20242023/Q491.524M / 90.429M--

Unlock Free Earnings Estimates

Coherus BioSciences Earnings Reports

  • Coherus BioSciences | 10-Q: Q2 2024 Earnings Report

    Aug 8 16:45 ET

  • Coherus BioSciences | 10-Q: Q1 2024 Earnings Report

    May 9 16:55 ET

  • Coherus BioSciences | 10-K: FY2023 Annual Report

    Mar 15 17:24 ET

  • Coherus BioSciences | 10-Q: Q3 2023 Earnings Report

    Nov 6, 2023 16:35 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 31, 2024

    Strong Buy

    • Buy

      85.71%

    • Hold

      14.29%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data